- Home
- ISPC vs TXMD Comparison
ISPC vs TXMD Comparison
Compare ISPC & TXMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ISPC
- TXMD
- Stock Information
- Founded
- ISPC 2009
- TXMD 2008
- Country
- ISPC United States
- TXMD United States
- Employees
- ISPC N/A
- TXMD N/A
- Industry
- ISPC Precision Instruments
- TXMD Biotechnology: Pharmaceutical Preparations
- Sector
- ISPC Health Care
- TXMD Health Care
- Exchange
- ISPC Nasdaq
- TXMD Nasdaq
- Market Cap
- ISPC 13.9M
- TXMD 12.3M
- IPO Year
- ISPC 2021
- TXMD N/A
- Fundamental
- Price
- ISPC $0.81
- TXMD $1.04
- Analyst Decision
- ISPC
- TXMD
- Analyst Count
- ISPC 0
- TXMD 0
- Target Price
- ISPC N/A
- TXMD N/A
- AVG Volume (30 Days)
- ISPC 1.3M
- TXMD 16.9K
- Earning Date
- ISPC 11-06-2025
- TXMD 11-11-2025
- Dividend Yield
- ISPC N/A
- TXMD N/A
- EPS Growth
- ISPC N/A
- TXMD N/A
- EPS
- ISPC N/A
- TXMD N/A
- Revenue
- ISPC $5,908,088.00
- TXMD $2,559,000.00
- Revenue This Year
- ISPC $35.93
- TXMD $427.09
- Revenue Next Year
- ISPC N/A
- TXMD N/A
- P/E Ratio
- ISPC N/A
- TXMD N/A
- Revenue Growth
- ISPC N/A
- TXMD 156.93
- 52 Week Low
- ISPC $0.64
- TXMD $0.70
- 52 Week High
- ISPC $8.30
- TXMD $2.44
- Technical
- Relative Strength Index (RSI)
- ISPC 37.44
- TXMD 40.86
- Support Level
- ISPC $0.92
- TXMD $1.03
- Resistance Level
- ISPC $1.33
- TXMD $1.09
- Average True Range (ATR)
- ISPC 0.12
- TXMD 0.03
- MACD
- ISPC -0.06
- TXMD -0.00
- Stochastic Oscillator
- ISPC 4.22
- TXMD 41.24
About ISPC iSpecimen Inc.
iSpecimen Inc is a technology-driven company focused on connecting life science researchers who need human biofluids, solid tissues, and hematopoietic stem and immune cells for their research, with the available biospecimens. The company generates revenue by procuring various specimens from hospitals, laboratories, and other supply sites. Geographically, it has a presence in the Americas; Europe, the Middle East, Africa, and Asia Pacific, which majority, comes from the Americas.
About TXMD TherapeuticsMD Inc.
TherapeuticsMD Inc is a pharmaceutical royalty company, currently receiving royalties on products licensed to pharmaceutical organizations that possess commercial capabilities in the relevant territories. The company and its subsidiaries (i) granted Mayne Pharma an exclusive license to commercialize its IMVEXXY, BIJUVA and prescription prenatal vitamin products sold under the BocaGreenMD and vitaMedMD brands (collectively, the "Licensed Products") in the United States and its possessions and territories, (ii) assigned to Mayne Pharma its exclusive license to commercialize ANNOVERA (together with the Licensed Products, collectively, the "Products") in the United States and its possessions and territories.